PUK Stock Analysis: Buy, Sell, or Hold?

PUK - PRUDENTIAL PLC ADS (REP 2 ORD SHARES)

Life Insurance
$32.99
-0.62 (-1.84%) ▼
HOLD
MODERATE Confidence
Protect Your PUK Gains
Last Updated: January 30, 2026
Earnings: Mar 19, 2026

Get Alerted When PUK Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: PUK is fairly valued with market pricing in 1.7% annual growth. Fine to hold or accumulate slowly on dips.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$51.82
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$32.18
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.4x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PUK is currently trading at $32.99, which is considered extended relative to its 30-day fair value range of $31.29 to $32.51. The stock's valuation (Forward PE: 14.2) is in line with its historical norms (13.4). At these levels, the market is pricing in 1.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, PUK is in a strong uptrend. The price is approaching resistance at $33.92. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: PUK has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $31.29 - $32.51
Company Quality Score 65/100 (BUY)
Volume Confirmation HIGH
Confidence Score 58.1%

Protect Your Profits

Holding PUK? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($36.99)
  • NEUTRAL: Market pricing in 1.7% annual earnings growth - fairly valued

Fair Price Analysis

30-Day Fair Range $31.29 - $32.51
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $31.13
Resistance Level $33.92
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 14.16
Wall Street Target $36.99 (+10.0%)
Revenue Growth (YoY) 20.4%
Earnings Growth (YoY) 1021.2%
Profit Margin 25.9%
Valuation Premium vs History +1.7% premium
PE vs Historical 14.2 vs 13.4 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.7% (market-implied from PE analysis)
1-Year Target $34.18 (+2%)
2-Year Target $34.76 (+3%)
3-Year Target $35.35 (+5%)
3-Yr Target (if PE normalizes) (PE: 14→13) PE COMPRESSION $33.45 (-1%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 16.7%) $84.07 (+150%)
Base: (SPY PE: 14.2, Growth: 16.7%) $53.39 (+59%)
Bear: (PE: 12.0, Growth: 16.7%) $45.38 (+35%)
📈 Valuation based on Current Earnings
Trailing PE: 12.89 | Current EPS (TTM): $2.57
Bull Case $33.66 (+2%)
Analyst growth -7.7%, PE expands to 14.2
Base Case $30.60 (-7%)
Market implied -7.7%, PE stable at 12.9
Bear Case $22.54 (-32%)
Severe decline -20.0%, PE contracts to 11.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 1:30 AM ET
Data refreshes hourly during market hours. Next update: 2:30 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Insurance - Life Stocks

Top-rated stocks in Insurance - Life by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
MET
MetLife Inc
STRONG BUY
16 analysts
$92 61 BUY
MFC
Manulife Financial Corp
BUY
13 analysts
$32 66 BUY
ABL
Abacus Life Inc.
STRONG BUY
5 analysts
$14 58 HOLD
UNM
Unum Group
BUY
12 analysts
$96 50 HOLD
GL
Globe Life Inc
BUY
10 analysts
$169 60 HOLD

Advanced PUK Option Strategies

Professional options setups generated by AI based on today's PUK price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PUK

PUK Technical Chart PUK Price Prediction PUK Earnings Date PUK Investment Advisor PUK Fair Price Analyzer PUK Options Advisor PUK Options Chain PUK Options Analysis PUK Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals